TIVC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TIVC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Tivic Health Systems's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.08 Mil. Its Revenue for the three months ended in Sep. 2024 was $0.13 Mil.
Tivic Health Systems's COGS to Revenue for the three months ended in Sep. 2024 was 0.65.
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Tivic Health Systems's Gross Margin % for the three months ended in Sep. 2024 was 34.92%.
The historical data trend for Tivic Health Systems's COGS-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tivic Health Systems Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
COGS-to-Revenue | 1.69 | 1.26 | 1.03 | 0.84 | 0.76 |
Tivic Health Systems Quarterly Data | ||||||||||||||||||
Dec19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
COGS-to-Revenue | Get a 7-Day Free Trial | 0.62 | 0.99 | 0.50 | 0.79 | 0.65 |
Tivic Health Systems's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as
COGS to Revenue | = | Cost of Goods Sold | / | Revenue |
= | 0.889 | / | 1.176 | |
= | 0.76 |
Tivic Health Systems's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as
COGS to Revenue | = | Cost of Goods Sold | / | Revenue |
= | 0.082 | / | 0.126 | |
= | 0.65 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tivic Health Systems (NAS:TIVC) COGS-to-Revenue Explanation
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.
Tivic Health Systems's Gross Margin % for the three months ended in Sep. 2024 is calculated as:
Gross Margin % | = | 1 | - | COGS to Revenue |
= | 1 | - | Cost of Goods Sold / Revenue | |
= | 1 | - | 0.082 / 0.126 | |
= | 34.92 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.
Thank you for viewing the detailed overview of Tivic Health Systems's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sheryle Bolton | director | 55 ALMADEN BLVD, SAN JOSE CA 95113 |
Dean Zikria | director | C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538 |
Jennifer Ernst | director, officer: Chief Executive Officer | 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025 |
Blake Gurfein | officer: Chief Scientific Officer | 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025 |
Ryan Sabia | officer: Chief Operating Officer | 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025 |
Kimberly Ann Bambach | officer: Interim CFO | 25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545 |
Karen Drexler | director | C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080 |
Veronica Cai | officer: Chief Financial Officer | C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080 |
John Claude | 10 percent owner | 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025 |
Briana Benz | officer: Chief Financial Officer | 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025 |
From GuruFocus
By Business Wire • 05-15-2024
By Business Wire • 05-13-2024
By Business Wire • 09-26-2023
By Business Wire • 07-23-2024
By Business Wire • 09-13-2024
By Business Wire • 08-22-2023
By Business Wire • 08-16-2023
By Business Wire • 10-29-2024
By Business Wire • 02-21-2024
By Business Wire • 11-12-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.